9. Risperidone and Paliperidone in the Treatment of Bipolar Disorder

  1. Hagop S. Akiskal3 and
  2. Mauricio Tohen4
  1. L. Ivo Caers1,2 and
  2. Joris Berwaerts1,2

Published Online: 13 APR 2011

DOI: 10.1002/9780470975114.ch9

Bipolar Psychopharmacotherapy: Caring for the Patient, Second Edition

Bipolar Psychopharmacotherapy: Caring for the Patient, Second Edition

How to Cite

Caers, L. I. and Berwaerts, J. (2011) Risperidone and Paliperidone in the Treatment of Bipolar Disorder, in Bipolar Psychopharmacotherapy: Caring for the Patient, Second Edition (eds H. S. Akiskal and M. Tohen), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470975114.ch9

Editor Information

  1. 3

    International Mood Center, University of California at San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0603, USA

  2. 4

    Department of Psychiatry, Division of Mood and Anxiety Disorders, University of Texas Health Science Centre at San Antonio, 7730 Floyd Curl Drive, San Antonio, TX 78229, USA

Author Information

  1. 1

    Johnson & Johnson Pharmaceutical Research & Development, LIC Beerse, Belgium

  2. 2

    Johnson & Johnson Pharmaceutical Research & Development, JB Titusville, NJ, USA

Publication History

  1. Published Online: 13 APR 2011
  2. Published Print: 15 APR 2011

ISBN Information

Print ISBN: 9780470747216

Online ISBN: 9780470975114

SEARCH

Keywords:

  • Paliperidone Extended Release (ER);
  • Young Mania Rating Scale (YMRS);
  • Risperidone Lai Studies;
  • Pediatric Studies;
  • Clinical Global Impression-Bipolar (CGI-BP)

Summary

This chapter contains sections titled:

  • Introduction

  • Oral risperidone in bipolar mania

  • Paliperidone extended release (ER) in bipolar mania

  • Risperidone long-acting injectable (LAI) in the maintenance treatment of bipolar disorder

  • Elements of special interest

  • Summary and conclusions

  • References